Phenotypic variety in the presentation of frontotemporal lobar degeneration
- PMID: 23611344
- DOI: 10.3109/09540261.2012.743877
Phenotypic variety in the presentation of frontotemporal lobar degeneration
Abstract
Frontotemporal lobar degeneration (FTLD) is a heterogeneous syndrome characterized by a progressive decline in behaviour or language associated with degeneration of the frontal and anterior temporal lobes. FTLD can be classified into three clinical syndromes based on the early and predominant symptoms: behavioural variant frontotemporal dementia (bvFTD); semantic dementia (SD); and progressive non-fluent aphasia (PNFA). Patients with bvFTD present with marked changes in personality and behaviour such as disinhibition, apathy, loss of sympathy, compulsive behaviours, hyperorality. Neuroimaging studies have highlighted frontal atrophy, hypometabolism and hypoperfusion. SD is characterized by a fluent anomic aphasia and behavioural changes with degeneration of the anterior temporal lobes. Patients with left-sided SD present with progressive loss of word knowledge and meaning about words, objects and concepts. Patients with PNFA present slow, effortful speech, impaired production and comprehension of grammar. PNFA is associated with atrophy, hypometabolism and hypoperfusion of the left perisylvian area. However, overlap between the syndromes can occur, particularly later in the course. In the absence of definitive biomarkers, the diagnosis is dependent on clinical symptoms. A new diagnostic criterion of bvFTD was published in 2011. Identification of the syndrome's core symptoms is important in clinical diagnosis.
Similar articles
-
[Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].Encephale. 2003 Mar-Apr;29(2):172-80. Encephale. 2003. PMID: 14567169 French.
-
[Clinical types of FTLD: progressive nonfluent aphasia; comparative discussions on the associated clinical presentations].Brain Nerve. 2009 Nov;61(11):1252-8. Brain Nerve. 2009. PMID: 19938681 Japanese.
-
Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.CNS Drugs. 2012 Oct 1;26(10):841-70. doi: 10.2165/11640070-000000000-00000. CNS Drugs. 2012. PMID: 22950490 Review.
-
Frontotemporal lobar degeneration: clinical and pathological relationships.Acta Neuropathol. 2007 Jul;114(1):31-8. doi: 10.1007/s00401-007-0236-3. Epub 2007 Jun 14. Acta Neuropathol. 2007. PMID: 17569065 Review.
-
Right temporal degeneration and socioemotional semantics: semantic behavioural variant frontotemporal dementia.Brain. 2022 Nov 21;145(11):4080-4096. doi: 10.1093/brain/awac217. Brain. 2022. PMID: 35731122 Free PMC article.
Cited by
-
Clinical and genetic analyses of familial and sporadic frontotemporal dementia patients in Southern Italy.Alzheimers Dement. 2017 Aug;13(8):858-869. doi: 10.1016/j.jalz.2017.01.011. Epub 2017 Mar 3. Alzheimers Dement. 2017. PMID: 28264768 Free PMC article.
-
Sirtuin 2 (SIRT2): Confusing Roles in the Pathophysiology of Neurological Disorders.Front Neurosci. 2021 May 24;15:614107. doi: 10.3389/fnins.2021.614107. eCollection 2021. Front Neurosci. 2021. PMID: 34108853 Free PMC article. Review.
-
Neuropsychological Assessment for Early Detection and Diagnosis of Dementia: Current Knowledge and New Insights.J Clin Med. 2024 Jun 12;13(12):3442. doi: 10.3390/jcm13123442. J Clin Med. 2024. PMID: 38929971 Free PMC article. Review.
-
Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive Impairment.J Alzheimers Dis. 2015;45(3):907-19. doi: 10.3233/JAD-142931. J Alzheimers Dis. 2015. PMID: 25633681 Free PMC article.
-
Efficacy of memantine on neuropsychiatric symptoms associated with the severity of behavioral variant frontotemporal dementia: A six-month, open-label, self-controlled clinical trial.Exp Ther Med. 2016 Jul;12(1):492-498. doi: 10.3892/etm.2016.3284. Epub 2016 Apr 20. Exp Ther Med. 2016. PMID: 27347084 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources